Federal Drug Price Negotiation : Implications for Medicare Part D.
Describes how Federal Government negotiates drug prices under existing public programs, presents arguments for and against such activities, and analyzes implications for pharmaceutical industry, Medicare beneficiaries, and others if similar Federal involvement were to occur for the Medicare Part D p...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2007.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Describes how Federal Government negotiates drug prices under existing public programs, presents arguments for and against such activities, and analyzes implications for pharmaceutical industry, Medicare beneficiaries, and others if similar Federal involvement were to occur for the Medicare Part D program under the Medicare Prescription Drug, Improvement, and Modernization Act. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |